Buspirone and Zolmitriptan Combination for Dyskinesia: A Randomized, Controlled, Crossover Study
{{output}}
Background: Preclinical evidence suggests that co-administration of the 5-HT1A agonist buspirone and the 5-HT1B/1D agonist zolmitriptan act synergistically to reduce dyskinesia to a greater extent than that achieved by either dru... ...
